routinely collected clinical data on 104 critically ill patients who had received an aminoglycoside ( gentamicin or tobramycin ) were evaluated using a proposed approach to forecast aminoglycoside-related nephrotoxicity .
C0040341
tobramycin
C0002556
aminoglycoside